John Eggbeer

Managing Director at Hercules Capital

John Eggbeer

John Eggbeer

Managing Director at Hercules Capital

Overview
RelSci Relationships

119

Contact Data
Trying to get in touch with John Eggbeer? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals John Eggbeer likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at Hercules Capital

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Hercules Capital, Inc.

Relationship likelihood: Strong

Associate General Counsel at Hercules Capital

Relationship likelihood: Strong

Senior Managing Director & Group Head Life Science at Hercules Capital

Relationship likelihood: Strong

Director of Investment Analysis & Strategy at Hercules Capital

Relationship likelihood: Strong

Managing Director, Technology Group at Hercules Capital

Relationship likelihood: Strong

Managing Director, Life Science Group at Hercules Capital

Relationship likelihood: Strong

Managing Director, Life Science Group at Hercules Capital

Relationship likelihood: Strong

Managing Director, Technology Group at Hercules Capital

Relationship likelihood: Strong

Managing Director, Life Science Group at Hercules Capital

Relationship likelihood: Strong

Paths to John Eggbeer
Potential Connections via
Relationship Science
You
John Eggbeer
Managing Director at Hercules Capital
Education
BS Business Administration

The University of Richmond (UR or U of R) is a private liberal arts university in Richmond, Virginia. The university is a primarily undergraduate, residential university with approximately 4,350 undergraduate and graduate students in five schools: the School of Arts and Sciences, the E. Claiborne Robins School of Business, the Jepson School of Leadership Studies, the University of Richmond School of Law and the School of Professional & Continuing Studies.

Career History
Managing Director
2011 - Current

Hercules Capital is an Independent Venture Capital firm provides growth capital to companies across all stages of development and specializes in venture debt in the forms of senior and subordinated working capital loans, senior revolving loans and bridge loans, venture leasing and select direct equity capital investments. The firm invests primarily in the technology and life sciences sectors such as computer hardware and software, networking systems and information technology infrastructure, internet services and telecommunications, medical devices, biopharmaceuticals and healthcare services. They provide financing in the form of senior secured term loans, senior lien loans, senior or junior mezzanine subordinate term loans, traditional growth capital loans, asset-based loans or revolvers, asset specific equipment loans, acquisition finance loans, public to private financing, PIPEs mezzanine loans and select private equity co-investments.

Senior Associate
2011 - Current

Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital.The company was founded by Manuel A. Henriquez in December 2003 and is headquartered in Palo Alto, CA.

Associate
2009 - 2011

MMV Financial focuses on investments in both private and public mid-market emerging technology and life sciences companies operating in the fields of IT opportunities in network management, semiconductor, wireless, enterprise & automation technology as well as life science-focused device and therapeutics located in the US and Canada. . The firm typically investment size of C$50 - C$60 million (C$3 - C$5 million in the form of debt). MMV Financial provides equity and debt (venture debt, bridge loan and structured loan) financing for early and mid-stage capital requirements.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John Eggbeer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John Eggbeer's profile does not indicate a business or promotional relationship of any kind between RelSci and John Eggbeer.